Haruaki Nobori

6PUBLICATIONS
29CO-AUTHORS
Molecular medicineNanomedicineCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 28, 2023
Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model.

Keita Fukao, Haruaki Nobori, Takayuki Kuroda

|Oct 13, 2023
2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses.

Kentaro Uemura, Haruaki Nobori, Akihiko Sato

|Feb 10, 2023
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo.

Takayuki Kuroda, Haruaki Nobori, Keita Fukao

|Nov 03, 2022
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.

Michihito Sasaki, Koshiro Tabata, Mai Kishimoto

|Aug 01, 2022
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model.

Haruaki Nobori, Keita Fukao, Takayuki Kuroda

|Jan 22, 2022
Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.

Keiichi Taniguchi, Yoshinori Ando, Masanori Kobayashi

Pageof 1

Frequent Collaborators

4 joint publications

Teruhisa Kato

3 joint publications

Takao Sanaki

3 joint publications

Takao Shishido

2 joint publications

Hirofumi Sawa